International Pharmaceutical Aerosol Consortium on Regulation & Science

IPAC-RS seeks to advance the science of orally inhaled and nasal drug products (OINDP) by collecting and analyzing data, and conducting joint research and development projects.

Learn More Join Today

News & Updates

IPAC-RS and University of Florida Collaboration

IPAC-RS has started work in collaboration with the University of Florida (UF) to study the modified chi-square ratio test of equivalence of aerodynamic particle size distributions.  UF had previously presented its research in this area to IPAC-RS as well as at public conferences and through publications (e.g., in the AAPS Journal).

Learn More

GRRO China Update - September 2015

IPAC-RS representatives were invited to and will participate in a symposium about the fundamentals of aerosols drugs organized by the National Institute for Food and Drug Control (NIFDC), a component of the Chinese FDA, and will chair and present at a session on materials quality and extractables/leachables at Inhalation Asia.

Learn More

Modified Chi-Square Ratio (MCSR)

An IPAC-RS collaboration with the University of Florida has been launched.  The group will study the MCSR tests combined with the Population Bioequivalence as recommended by FDA for determination of equivalence in Aerodynamic Particle Size Distributions.

Learn More

Upcoming Events


Become an IPAC-RS member today

Sign Up

IPAC-RS members can sign up to receive our biweekly update on IPAC-RS and regulatory developments.